Zusammenfassung
Bei Niereninsuffizienz besteht eine erhöhte Inzidenz für das Auftreten peptischer Ulzera und gastrointestinaler Blutungen, die z T.auf eine Magensäurehypersekretion, z T.auf eine Hyper- gastrinämie zurückgeführt werden (Goldstein et al. 1967; Ritz et al. 1971; Venkateswaran et al. 1972; Shepherd et al. 1973; Milito et al. 1983, 1985).
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Literatur
Brodde OE & Daul A (1984). Alpha- and beta-adrenoceptor changes in patients on maintenance hemodialysis. Contrib. Nephrol., 41, 99–107.
Daul AE, Khalifa AM, Graven N & Brodde OE (1984). Impaired regulation of ß-adrenoceptors in patients on maintenance haemodialysis. Proc. Proc Eur Dial Transplant Assoc, 21, 178–183.
Garg DC, Weidler DJ & Eshelman FN (1983). Ranitidine bioavailability and kinetics in normal male subjects. Clin. Pharmacol. Ther., 33, 445–452.
Goldstein H, Murphy D, Sokol A & Rubini ME (1967). Gastric acid secretion in patients undergoing chronic dialysis. Arch. Intern. Med.,. 120, 645–653.
Halstenson CE, Abraham PA, Opsahl JA, Keane WF, Kovarik JM, Chremos AN & Matzke GR (1986). Disposition of famotidine (F) in renal insufficiency. Clin. Pharmacol. Ther., 39, 197.
Jones RH, Lewin MR & Parsons V (1979). Therapeutic effect of Cimetidine in patients undergoing haemodialysis. Brit. Med. J., 1, 650–652.
Knoben JE & Anderson PO (1983). In: Hand Book of Clinical Drug Data in 5th Edn, pp 36. Illinois. Drug intelligence Publications.
Kroemer H & Klotz U (1987). Pharmacokinetics of famotidine in man. Int. J. Clin. Pharmacol. Ther. Toxicol. 25, 458–463.
Mann JFE, Hausen M, Jacobs KH, Kutter A, Nagel W, Rascher W, Schick M, Sudhoff R & Ritz E (1984). Adrenergic responsiveness in experimental uremia. Contrib. Nephrol., 41, 108–112.
Milito G, Taccone-Gallucci M, Brancaleone C, Nardi F, Fillingeri V, Cesca D & Casciani CU (1983). Assessment of the upper gastrointestinal tract hemodialysis patients awaiting renal transplantation. Am J Gastroenterol. 78, 328–331.
Milito G, Taccone-Gallucci M, Brancaleone C, Nardi F, Cesca D, Boffo V & Casciani CU (1985). The gastrointestinal tract in uremic patients on long-term hemodialysis. Kidney Int., 28, suppl. 17, S - 157 - 160
Peck CC & Barrett BB (1979). Nonlinear Least-Squares Regression Programs for micro-computers. J Pharmacokinet Biopharm., 5, 537 - 541
Ritz E, Krempien B, Wanke M, Ziegler M, Wesch G & Torner U (1971). Klinische und experimentelle Untersuchungen zur urämischen Gastritis. Verh. Dtsch. Ges. Inn. Med., 77, 220 - 224
Schäfer U, Stiller S & Mann H (1986). Measurement of solute balance during dialysis therapy, Life support Systems - Abstracts XIII. Annual Meeting Europ. Soc. Artif. Organs, Avigon, pp 237 - 239
Shepherd, AMM, Stewart WK & Wormsley KG (1973). Peptic ulceration in chronic renal failure. Lancet., 1, 1357 - 1359
Sica DA, Comstock T, Harford A & Eshelman F (1987). Ranitidine pharmacokinetics in continuous ambulatory peritoneal dialysis. Eur. J. Clin. Pharmacol., 32, 587 - 591
Smith JL, Gamal MA, Chremos AN & Graham DY (1985). Famotidine, a new H2-receptor antagonist: effect on parietal, nonparietal and pepsin secretion in man. Dig Dis Sei, 30, 308 - 312
Takabatake T, Ohta H, Maekawa M, Yamamoto Y, Ishida Y, Hara H, Saburo N, Shioki Y, Kawabata M, Hashimoto N & Hattori N (1983). Pharmacokinetics of famotidine in patients with renal insufficiency. Med Consultation, New Remedies., 20, 2061 - 2068
Takabatake T, Ohta H, Maekawa M, Yamamoto Y, Ishida Y, Hara H, Nakamura S, Ushiogi Y, Kawabata M, Hashimoto N & Hattori N (1985). Pharmacokinetics of famotidine, a new H2-receptor antagonist, in relation to renal function. Eur. J. Clin. Pharmacol. 28, 327 - 331
Takabatake T, Ohta H, Yamamoto Y, Ishida Y, Hara H, Nakamura S, Ushiogi Y, Kawabata M, Hashimoto N, Satoh S, Sasaki T, Yamada Y, Ohta K & Hattori N (1986). Pharmacokinetics and dosage requirements of famotidine: a new H2-receptor antagonist, in renal failure. Dig Dis Sei 31, (Suppl), 274 S.
Venkateswaran PS, Jeffers A & Hocken AG (1972). Gastric acid secretion in chronic renal failure. Brit. Med. J., 4, 22 - 23
Wagner JG (1975). Linear compartment models. In Fundamentals of Clinical Pharmacokinetics, pp 57 - 128, Illinois, Drug Int. Pub
Rights and permissions
Copyright information
© 1989 Springer-Verlag Berlin Heidelberg
About this paper
Cite this paper
Gladziwa, U., Klotz, U., Krishna, D.R., Schmitt, H., Glöckner, W.M., Mann, H. (1989). Pharmakokinetik und -dynamik von Famotidin bei Patienten mit terminaler Niereninsuffizienz. In: Famotidin heute. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-73807-4_10
Download citation
DOI: https://doi.org/10.1007/978-3-642-73807-4_10
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-73808-1
Online ISBN: 978-3-642-73807-4
eBook Packages: Springer Book Archive